Moderna Inc. (MRNA) Fundamentals

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 44 mRNA development programs as of early 2022, with 25 of these in clinical trials. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
SHARE INFORMATION
Market Cap$ 73,091,722,801
Shares Outstanding391,199,544
Float290,094,600
Percent Float74.16%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 17,736,000,000
Latest Fiscal EPS$ 28.29
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions2,231
Institutional Holdings Date2022-07-31
Institutional Bought Previous 3 Months37,481,705
Institutional Holdings Percent112.6%
Institutional Sold Previous 3 Months37,584,457
Insider Holdings Date2022-07-31
Insider Bought Previous 3 Months1,077,007
Insider Holdings Percent5.7
Insider Sold Previous 3 Months2,056,655
Insider Shares Owned22,867,687
TRADING INFO
52 Week High$ 497.49
52 Week Low$ 115.61
52 Week High Change$ -55.11
21 Day Moving Average$ 169.0119
21 Day Extended Moving Average$ 167.5473
50 Day Moving Average$ 152.1046
50 Day Extended Moving Average$ 158.7293
200 Day Moving Average$ 190.1068
200 Day Extended Moving Average$ 181.0405
10 Day Average Volume5,037,568
20 Day Average Volume4,603,801
30 Day Average Volume4,948,678
50 Day Average Volume5,276,129
Alpha0.068763
Beta1.6010
Standard Deviation0.292389
R20.087503
7 Day Price Change$ 22.75
7 Day Percent Change13.86%
21 Day Price Change$ 19.93
21 Day Percent Change11.94%
30 Day Price Change$ 31.30
30 Day Percent Change20.12%
Month to Date Price Change$ 22.75
Month to Date Percent Change13.86%
Quarter to Date Price Change$ 43.99
Quarter to Date Percent Change30.79%
180 Day Price Change$ 23.83
180 Day Percent Change14.62%
200 Day Price Change$ -17.89
200 Day Percent Change-8.74%
Year to Date Price Change$ -67.14
Year to Date Percent Change-26.44%

Moderna Inc. (MRNA) Key Ratios

PROFITABILITY
EBIT Margin70.4%
EBITDA Margin71.8%
Pre-Tax Profit Margin-257.0%
Profit Margin Count62.83%
Gross Margin81.7%
Profit Margin TOT62.83%
INCOME STATEMENTS
Revenue$ 22,284,000,000
Revenue Per Share$ 56.9633
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book4.10
Total Debt To Equity0.10
Int Coverage747.00
Current Ratio2.00
Leverage Ratio1.70
Quick Ratio1.60
Long Term Debt To Capital0.04
VALUATION MEASURES
PE Ratio5.70
Enterprise Value$ 66,081,722,800
Price to Sales3.28
Price to Free Cash7.90
PE High Last 5 Years0.00
Price To Book4.10
Price To Cash Flow8.30
PE Low Last 5 Years0.00
Price to Tangible Book4.10
MANAGEMENT EFFECTIVENESS
Receivables Turnover10.40
Invoice Turnover3.30
Assets Turnover1.30
Return Assets69.72
Return on Equity117.57
Return on Capital107.07

Moderna Inc. (MRNA) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorErnst & Young LLP
CEOStephane Bancel
Emplyoees2700
Last AuditUQ
CIK0001682852
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address200 Technology Square
Cambridge, MA 2139
Websitehttps://www.modernatx.com
Facsimile+1 617 583-1998
Telephone+1 617 714-6500
EmailLavina.Talukdar@modernatx.com


Your Recent History
NASDAQ
MRNA
Moderna
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.